Antimullerian Hormone, SerumPrint this page
Updated Test Information:
Antimullerian Hormone, Serum
Mullerian inhibiting factor (MIF)
Preferred: Serum gel
Refrigerated (preferred): 7 days
|Unacceptable Specimen Conditions||
Gross hemolysis: acceptable to 1000 mg/dL
Interference was observed at biotin concentrations above 30 ng/mL. Samples should not be taken from patients receiving therapy with high biotin doses until at least 12 hours following the last biotin administration.
The following drugs may interfere with this test: Cetrotide, Ovitrelle, Endometrin and Follistatin: do not use this test to analyze samples from patients who have received 1 or more of these products within 1 to 2 weeks of testing.
There is no high-dose hook effect at AMH concentrations up to 1400 ng/mL.
In rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur. The laboratory should be alerted if the result does not correlate with the clinical presentation.
For diagnostic purposes, the results should always be assessed in conjunction with the patient’s medical history, clinical examination and other findings.
AMH immunoassays are not standardized and values obtained with different assay methods or kits may be different and cannot be used interchangeably.
If using as a tumor marker, test results cannot be interpreted as absolute evidence for the presence or absence of malignant disease.
Electrochemiluminescent Immunoassay (ECLIA)
|Minimum Sample Volume|
<2 years: 18-283 ng/mL
2-12 years: 8.9-109 ng/mL
>12 years: <13 ng/mL
<3 years: 0.11-4.2 ng/mL
3-6 years: 0.21-4.9 ng/mL
7-11 years: 0.36-5.9 ng/mL
12-14 years: 0.49-6.9 ng/mL
15-19 years: 0.62-7.8 ng/mL
20-24 years: 1.2-12 ng/mL
25-29 years: 0.89-9.9 ng/mL
30-34 years: 0.58-8.1 ng/mL
35-39 years: 0.15-7.5 ng/mL
40-44 years: 0.03-5.5 ng/mL
45-50 years: <2.6 ng/mL
51-55 years: <0.88 ng/mL
>55 years: <0.03 ng/mL